Knockdown of HCK promotes HREC cell viability and inner blood-retinal barrier integrity by regulating the AMPK

Lu Chen1, Chengmin Lin2

  • 1Ophthalmology Teaching and Research Office, Zhejiang Industry & Trade Vocational College, Wenzhou, Zhejiang, 325000, China.

Open Life Sciences
|September 9, 2024
PubMed

Insights

Hematopoietic cell kinase (HCK) shows increased expression in diabetic retinopathy (DR) under high glucose conditions. Targeting HCK may improve retinal cell viability and blood-retinal barrier integrity, offering new therapeutic strategies for DR.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic retinopathy (DR) is a leading cause of blindness due to diabetes-related retinal damage.
  • Current treatments for DR are limited, necessitating the identification of novel therapeutic targets.
  • Hematopoietic cell kinase (HCK) has emerged as a potential biomarker in DR, but its specific role is unclear.

Purpose of the Study:

  • To investigate the role of HCK in the progression of diabetic retinopathy.
  • To elucidate the underlying mechanisms of HCK action in high glucose-induced retinal damage.

Main Methods:

  • Human retinal capillary endothelial cells (HRECs) were cultured and exposed to high glucose (HG) conditions.
  • HCK expression levels were measured.
  • HCK was knocked down using specific techniques.
  • Cell viability and blood-retinal barrier integrity were assessed.
  • The AMPK pathway was analyzed in response to HCK depletion.

Main Results:

  • High glucose stimulation led to increased HCK expression in HRECs.
  • Knockdown of HCK significantly improved HREC cell viability.
  • HCK depletion enhanced the integrity of the internal blood-retinal barrier.
  • Suppression of the AMPK pathway was observed upon HCK depletion in HG-induced HRECs.

Conclusions:

  • HCK plays a significant role in the pathogenesis of diabetic retinopathy.
  • Targeting HCK presents a promising therapeutic strategy for DR.
  • HCK modulation impacts the AMPK pathway, offering a potential mechanism for treatment.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K